Skip to main content

Find Clinical Trials

Home
Conditions
Parathyroid Diseases

Clinical trial condition

Parathyroid Diseases

Explore clinical trials studying Parathyroid Diseases. Study availability and eligibility vary by location and protocol.

441 public trials 75 recruiting studies

Refine in advanced search Browse all conditions

Parathyroid Diseases trial results

Completed

Observational Program of Zemplar in Patients With End Stage Chronic Kidney Disease and Parathyroid Disorder on Hemodialysis in the Russian Federation

NCT01401478

Conditions: Chronic Disease, Disease Attributes, Endocrine System Diseases, +14 more
Locations: Site Reference ID/Investigator# 57348 Al'met'yevsk, Russia

Site Reference ID/Investigator# 57347 Cheboksary, Russia

Site Reference ID/Investigator# 58347 Chelyabinsk, Russia

Site Reference ID/Investigator# 67404 Iakutsk, Russia

View all 13 locations

View Trial Details

Completed

Study to Assess Patient Management Practices and Quality of Life With Paricalcitol Capsules in the Treatment of Secondary Hyperparathyroidism in Stage 3-5 Chronic Kidney Disease Patients Not Yet on Dialysis

NCT01265992

Conditions: Avitaminosis, Bone Diseases, Bone Diseases, Metabolic, +29 more
Locations: Site Reference ID/Investigator# 47723 Kalmar, Sweden

Site Reference ID/Investigator# 41084 Karlstad, Sweden

Site Reference ID/Investigator# 45190 Kristianstad, Sweden

Site Reference ID/Investigator# 41085 Linköping, Sweden

View Trial Details

Completed

ACHIEVE: Optimizing the Treatment of Secondary Hyperparathyroidism

NCT00135304

Conditions: Chronic Disease, Disease Attributes, Endocrine System Diseases, +14 more
Locations: Not specified

View Trial Details

Completed

Effect of Vitamin D Treatment in Primary Hyperparathyroidism

NCT00674154

Conditions: Avitaminosis, Calcium Metabolism Disorders, Deficiency Diseases, +12 more
Locations: Osteoporoseklinikken, Aarhus University Hospital, THG Aarhus C, Denmark

View Trial Details

Completed

Cincalcet and Vascular Arterial Stiffness Among Peritoneal Dialysis Patients With Secondary Hyperparathyroidism

NCT01143987

Conditions: Arterial Stiffness, Chronic Disease, Disease Attributes, +14 more
Locations: Prince of Wales Hospital, Chinese University of Hong Kong Shatin, New Territories, Hong Kong

View Trial Details

Completed

Near Infrared Fluorescent Imaging in Thyroid and Parathyroid Surgery With the Fluobeam(TM) System of Fluoptics

NCT01598727

Conditions: Endocrine System Diseases, Hyperparathyroidism, Hyperparathyroidism, Primary, +2 more
Locations: Department of General Surgery Sheffield, South Yorkshire, United Kingdom

View Trial Details

Completed

A Prospective Cohort Study to Describe the Evolution of Persistent Hyperparathyroidism in Kidney Transplant Recipients

NCT01163669

Conditions: Endocrine System Diseases, Hyperparathyroidism, Parathyroid Diseases
Locations: Cleveland Clinic Cleveland, Ohio, United States

View Trial Details

Completed

OPG/Soluble RANKL (sRANKL) and Bone Mineral Density in Primary Hyperparathyroidism

NCT01889134

Conditions: Endocrine System Diseases, Hyperparathyroidism, Hyperparathyroidism, Primary, +2 more
Locations: Department of Endocrinology, Diabetology and Isotope Therapy, Wroclaw Medical University Wroclaw, Poland

View Trial Details

Completed

Short- and Long-Term Impact of Subtotal Parathyroidectomy on the Achievement of Bone and Mineral Parameters Recommended by Clinical Practice Guidelines in Dialysis Patients

NCT01872429

Conditions: Endocrine System Diseases, Hyperparathyroidism, Parathyroid Diseases
Locations: Far Eastern Memorial Hospital New Taipei City, Taiwan

View Trial Details

Completed

Comparison of Efficacy and Safety of Paricalcitol Injection With Maxacalcitol Injection in Adult Japanese Chronic Kidney Disease Subjects Receiving Hemodialysis With Secondary Hyperparathyroidism

NCT01341782

Conditions: Endocrine System Diseases, Hemodialysis, Hyperparathyroidism, +3 more
Locations: Site Reference ID/Investigator# 53485 Aichi, Japan

Site Reference ID/Investigator# 51571 Chiba, Japan

Site Reference ID/Investigator# 52963 Chiba, Japan

Site Reference ID/Investigator# 52966 Chiba, Japan

View all 45 locations

View Trial Details